Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

RedHill Biopharma Announces Confirmatory Phase III Study Initiated with RHB-105 (TALICIA™) for H. py

b3cnewswireJune 16, 2017

Tag: RedHill Biopharma , RHB-105 (TALICIA™)

PharmaSources Customer Service